In view of the important role of IDH1/2 mutations in the occurrence and development of glioma, studies of these proteins may enable researchers to identify appropriate inhibitors and intervene in the treatment of glioma patients with IDH1/2 mutations. The gene discussed is IDH1; the disease is glioma.